Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 825704109 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Cadian Capital Management, LP
13G
|
7.5% |
8/14/2026
Event 6/30/2026
|
|
| Cadian Capital Management, LP | 7.5% | ||
| Cadian Capital Management GP, LLC | 7.5% | ||
| Eric Bannasch | 7.5% | ||
| BlackRock, Inc. 13G/A Amendment 7 | 8.0% |
7/30/2026
Event 6/30/2026
|
|
|
First Light Asset Management, LLC
13G/A
Amendment 1
|
18.4% |
5/7/2026
Event 4/30/2026
|
|
| First Light Asset Management, LLC | 18.0% | ||
| Mathew P. Arens | 18.4% | ||
| BlackRock, Inc. 13G/A Amendment 6 | 6.9% |
4/24/2026
Event 3/31/2026
|
|
| Vanguard Group Inc 13G/A Amendment 1 | 0% |
3/27/2026
Event 3/13/2026
|
|
|
OrbiMed Capital LLC
13G/A
Amendment 6
|
0% |
2/17/2026
Event 12/31/2025
|
|
| OrbiMed Capital LLC | 0% | ||
| OrbiMed Advisors LLC | 0% | ||
|
Brown Advisory Inc
13G/A
Amendment 5
|
5.8% |
2/13/2026
Event 12/31/2025
|
|
| Brown Advisory Inc | 5.8% | ||
| Brown Investment Advisory & Trust Co | <0.1% | ||
| Brown Advisory LLC | 5.8% | ||
| Signature Financial Management, Inc. | <0.1% | ||
| Brown Advisory Ltd | <0.1% | ||
|
American Century Investment Management, Inc.
13G/A
Amendment 3
|
5.3% |
2/13/2026
Event 12/31/2025
|
|
| American Century Mutual Funds, Inc. | 4.1% | ||
| American Century Investment Management, Inc. | 5.3% | ||
| American Century Companies, Inc. | 5.3% | ||
| Stowers Institute for Medical Research | 5.3% | ||
| Champlain Investment Partners, LLC 13G | 4.9% |
2/12/2026
Event 9/30/2025
|
|
|
First Light Asset Management, LLC
13G
|
11.9% |
12/5/2025
Event 11/30/2025
|
|
| First Light Asset Management, LLC | 11.6% | ||
| Mathew P. Arens | 11.9% | ||
|
American Century Investment Management, Inc.
13G/A
Amendment 2
|
6.6% |
11/14/2025
Event 9/30/2025
|
|
| American Century Mutual Funds, Inc. | 5.3% | ||
| American Century Investment Management, Inc. | 6.6% | ||
| American Century Companies, Inc. | 6.6% | ||
| Stowers Institute for Medical Research | 6.6% | ||
|
OrbiMed Capital LLC
13G/A
Amendment 5
|
5.1% |
8/14/2025
Event 6/30/2025
|
|
| OrbiMed Capital LLC | 5.1% | ||
| OrbiMed Advisors LLC | 0.9% | ||
| Champlain Investment Partners, LLC 13G | 5.0% |
8/12/2025
Event 6/30/2025
|
|
|
OrbiMed Capital LLC
13G/A
Amendment 4
|
7.0% |
5/15/2025
Event 3/31/2025
|
|
| OrbiMed Capital LLC | 7.0% | ||
| OrbiMed Advisors LLC | 1.1% | ||
|
American Century Investment Management, Inc.
13G/A
Amendment 1
|
6.2% |
5/15/2025
Event 3/31/2025
|
|
| American Century Investment Management, Inc. | 6.2% | ||
| American Century Companies, Inc. | 6.2% | ||
| Stowers Institute for Medical Research | 6.2% | ||
|
Brown Advisory Inc
13G/A
Amendment 4
|
7.6% |
4/18/2025
Event 3/31/2025
|
|
| Brown Advisory Inc | 7.6% | ||
| Brown Investment Advisory & Trust Co | 0% | ||
| Brown Advisory LLC | 7.5% | ||
| Signature Financial Management, Inc. | 0% | ||
| BlackRock, Inc. 13G/A Amendment 5 | 8.1% |
4/17/2025
Event 3/31/2025
|
|
| Champlain Investment Partners, LLC 13G | 6.7% |
11/12/2024
Event 9/30/2024
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 3 | 2.13 k | $40.1 k |
| 2026 Q2 | 174 | 48.9 M | $831 M |
| 2026 Q1 | 186 | 43.4 M | $549 M |
| 2025 Q4 | 191 | 41.4 M | $816 M |
| 2025 Q3 | 179 | 42.0 M | $619 M |
| 2025 Q2 | 182 | 41.2 M | $776 M |
| 2025 Q1 | 164 | 40.5 M | $568 M |
| 2024 Q4 | 150 | 39.8 M | $546 M |
| 2024 Q3 | 141 | 40.9 M | $571 M |
| 2024 Q2 | 150 | 41.5 M | $534 M |
| 2024 Q1 | 159 | 42.6 M | $697 M |
| 2023 Q4 | 164 | 40.7 M | $854 M |
| 2023 Q3 | 155 | 38.9 M | $826 M |
| 2023 Q2 | 176 | 37.8 M | $1.02 B |
| 2023 Q1 | 123 | 33.5 M | $659 M |
| 2022 Q4 | 108 | 34.4 M | $469 M |
| 2022 Q3 | 115 | 33.8 M | $591 M |
| 2022 Q2 | 116 | 34.4 M | $454 M |
| 2022 Q1 | 119 | 32.5 M | $732 M |
| 2021 Q4 | 125 | 32.4 M | $720 M |
| 2021 Q3 | 131 | 31.2 M | $668 M |
| 2021 Q2 | 141 | 30.6 M | $962 M |
| 2021 Q1 | 139 | 29.2 M | $966 M |
| 2020 Q4 | 139 | 26.3 M | $786 M |
| 2020 Q3 | 100 | 21.2 M | $503 M |
| 2020 Q2 | 85 | 19.2 M | $316 M |
| 2020 Q1 | 83 | 18.9 M | $225 M |
| 2019 Q4 | 64 | 14.1 M | $302 M |
| 2019 Q3 | 68 | 12.8 M | $226 M |
| 2019 Q2 | 63 | 11.2 M | $227 M |
| 2019 Q1 | 45 | 9.55 M | $180 M |
| 2018 Q4 | 52 | 9.69 M | $202 M |